Cite
HARVARD Citation
Thieblemont, C. et al. (2020). Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study. British journal of haematology. pp. 84-96. [Online].